2024 AAN Presentation

2024 AAN Presentation:

 

A phase 1 study, INTERCEPT-AD, of ACU193: safety, target engagement, and biomarker changes.

File Type: pdf
File Size: 502 KB
Categories: 2024
Tags: 2024, AAN, Biomarkers, INTERCEPT-AD, Presentation, Target Engagement, TwentyTwentyFour